| Date | Title | Description |
| 21.03.2024 | Biological progress or bathtub brews? The state of US crop biologicals in 2024 | Bathtub brew. Snake oil. Bugs in a jug. For years, companies developing biologicals — a form of crop protection derived from naturally occurring substances like microbes, peptides, and plants — have labored under the shadow of these labels,... |
| 31.03.2023 | What M&A slowdown? Buyers circle GreenLight Biosciences, Egetis Therapeutics | While biotech M&A may have cooled down over the past year, no one has told GreenLight Biosciences or Egetis Therapeutics, which are both mulling takeover offers.
RNA-focused GreenLight announced yesterday that it has received an offer f... |
| 12.10.2022 | Despite $109M influx in August, GreenLight Biosciences brings out the axe to chop a quarter of its staff | As staff reductions romp across the industry, the RNA R&D and manufacturing company GreenLight Biosciences is the latest to bring out the axe.
The company said Wednesday it is reducing staff by 25% as part of a wider r... |
| 12.08.2022 | GreenLight Biosciences announces $109 million financing | BOSTON, Aug. 12, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to bring effective and safe solutions to make food clean and affordable for everyone and dedicated to developing health s... |
| 01.08.2022 | GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine | GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities
Technology transfer and scale-up from lab bench to Samsung's commercial facility was completed in seven months
GreenLight's mRNA synth... |
| 22.03.2022 | AgFunder captures increasing, urgent investor demand for agrifoodtech with $60m Fund IV first close | Disclosure: AgFunder is AFN’s parent company.
AgFunder, one of the world’s most active investors in foodtech and agtech startups, has increased its assets under management to $160 million – 10x in two years – with the first close of its fou... |
| 21.03.2022 | To raise a fund, this agtech outfit built a content company first (now it has $60 million to put to work) | Rob Leclerc has the kind of pedigree that investors tend to like. He has a masters degree in computer science from the University of Calgary and a PhD in computational biology from Yale. In fact, ten years ago, what he really wanted to do w... |
| 04.02.2022 | Brief: Greenlight Biosciences completes $1.2bn merger to list on Nasdaq, closes up 5% | Disclosure: AFN’s parent company, AgFunder, is an investor in Greenlight Biosciences.
Greenlight Biosciences, which develops RNA products for agriculture and human health — including Covid-19 vaccines — became a publicly traded company yest... |
| 24.11.2021 | GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing | BOSTON and INCHEON, South Korea, Nov. 24, 2021 /PRNewswire/ -- GreenLight Biosciences (Nasdaq: ENVI), a biotechnology company dedicated to making ribonucleic acid (RNA) products affordable and accessible for human health and agriculture, an... |
| 12.08.2021 | Data Snapshot: Ag biotech was fastest-growing farm tech funding category in 2020 | AFN‘s parent company AgFunder released the latest edition of its annual Farm Tech Investment Report earlier this month, which showed that funding for agritech startups saw its biggest increase since 2018.
FY 2020 global investment into the ... |
| 11.08.2021 | Environmental Impact Acquisition : Press Release, dated August 10, 2021 (Form 8-K) | GreenLight Biosciences announces business agreement with Environmental Impact Acquisition Corp. to become publicly traded company, allowing it to better harness its breakthrough platform to develop and produce RNA for human therapies and ag... |
| 10.08.2021 | Baird Capital Portfolio Company ‘GreenLight’ to Become Publicly Traded Company | Today, Baird Capital portfolio company GreenLight Biosciences (“GreenLight”) announced its plans to become publicly listed through a business combination with the SPAC Environmental Impact Acquisition Corp. (Nasdaq: ENVI). |
| 10.08.2021 | Brief: GreenLight Biosciences agrees to go public in $1.2bn SPAC merger | GreenLight Biosciences, an ag biotech company using the RNA technology made famous by Covid-19 vaccines, has agreed to merge with a special purpose acquisition company (SPAC) in a deal that will value the company at $1.2 billion and list it... |
| 04.08.2021 | Farm tech investing is accelerating faster than ever – new report | Editor’s note: A version of this article previously appeared in Forbes.
We’ve been watching the surge of investor interest in upstream, close-to-the-farm technologies since the Covid-19 pandemic started. We now have numbers that show just h... |
| 29.07.2021 | Farm Tech Investing Is Accelerating Faster Than Food Tech And General VC - New Report | As devastating as the pandemic has been, some good has emerged from the global health and economic crisis: investment to shore up global food systems has soared. Back in February we confirmed the extent of the boost investors gave entrepren... |
| 08.07.2021 | Micropep’s small peptide ag inputs get $10m from FMC, others | Micropep Technologies, a startup developing peptide-based biological inputs for farms, has raised €8.5 million ($10 million) in Series A funding.
The round was led by Paris-based Supernova Invest. FMC Ventures, the corporate VC arm of US ag... |
| 08.07.2021 | BREAKING: Micropep’s small peptide ag inputs get $10m from FMC, others | Micropep Technologies, a startup developing peptide-based biological inputs for farms, has raised €8.5 million ($10 million) in Series A funding.
The round was led by Paris-based Supernova Invest. FMC Ventures, the corporate VC arm of US ag... |
| 23.06.2021 | Behind the scenes at the top agrifood CVCs | Furious dealmaking in the agrifoodtech sector last year yielded a surprising result: in 12 months marked by immense uncertainty, agrifood investors took bigger risks. They backed cell-cultured meat startups, insect farms, biotech companies ... |
| 23.06.2021 | NEW REPORT: Behind the scenes at the top agrifood CVCs | Furious dealmaking in the agrifoodtech sector last year yielded a surprising result: in 12 months marked by immense uncertainty, agrifood investors took bigger risks. They backed cell-cultured meat startups, insect farms, biotech companies ... |
| 03.03.2021 | The key ingredient that could hold back vaccine manufacturing | As vaccines are distributed around the world, an effective end to the Covid-19 pandemic seems to be on the horizon. There’s a new vaccine from Johnson & Johnson now being delivered, with supplies soon to be boosted by a deal with the ph... |
| 30.12.2020 | The 20 highest-funded agrifoodtech startups of 2020 | It safe to say that 2020 has been a difficult year for many of us – to say the very least. But as the global Covid-19 pandemic has rumbled on, agrifoodtech startups have continued to attract capital from investors.
They’ve had to work even ... |
| 02.11.2020 | What 2020 has taught the agrifood sector: resilience | If there is anything the world has learned from the pandemic about the future of food it’s that food chains need to be more resilient. Ireland is a case study in how to achieve it.
The small European island country was reeling after the glo... |
| 02.10.2020 | Targeted RNA crop protection – the next frontier in biopesticides | Editor’s note: Joe Hanson is director of market development at GreenLight Biosciences in Medford, Massachusetts. GreenLight Sciences is a portfolio company of AgFunder, which is AFN‘s parent company.
Agricultural pests lead to more than $10... |
| 08.09.2020 | How to spot opportunities and land funding in agriculture tech, the multibillion-dollar industry that's only becoming more crucial with population growth | Tortuga AgTech robots. Tortuga AgTech This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Redeem now
Conventional farming methods are unable to produce enough food to feed the world’s growing... |
| 18.08.2020 | Dealmaking during Covid-19: Upstream and eGrocery win in AgFunder’s 2020 Mid-Year Investment Review | We’re just over halfway through 2020. And while this may already feel like the longest year on record, agrifoodtech startups and investors are plugging away as if we weren’t all caught in the midst of a global pandemic. Almost.
Committed ca... |
| 17.06.2020 | How the Colorado potato beetle inspired a $102 million fundraise – and could yet inspire a Covid-19 vaccine | UPDATE: Wednesday June 17, 4:55pm ET to add comments from GreenLight investor S2G.
Switching sharply to developing a vaccine for Covid-19 appears to have proved a boon for GreenLight Biosciences, a company that previously focused on develop... |
| 16.06.2020 | GreenLight Biosciences closes $102M Series D funding to expand production of its RNA products for agricultural and life sciences applications | GreenLight Biosciences, a Medford, MA-based biotech startup focused on sustainable production of chemicals and fuels, today announced it has raised $102 million in Series D funding to rapidly expand production of its RNA products for agricu... |
| 16.06.2020 | GreenLight Biosciences raises $102M in Series D to bring RNA products to 'patients and farmers alike' | With a renewed focus on bringing sustainable biopesticides and a coronavirus vaccine to market, GreenLight Biosciences, the rapidly growing agtech and life sciences firm based in Medford, has brought in a whopping $102 million in Series D f... |
| 16.06.2020 | GreenLight Biosciences Closes $102M Series D To Expand RNA Products | 14 Shares Email Facebook Twitter LinkedIn
GreenLight Biosciences raised an oversubscribed $102 million Series D funding round, enabling the Boston-based company to rapidly expand production of its RNA products for agricultural and life scie... |
| 16.06.2020 | GreenLight Biosciences Supercharges Its Efforts With $102M Series D Funding | GreenLight Biosciences today announced it has raised an oversubscribed $102 million round of funding from new and existing investors to rapidly expand production of its RNA products for agricultural and life sciences applications, including... |
| 16.06.2020 | GreenLight Biosciences Closes $102M Series D To Expand RNA Products | 18 Shares Email Facebook Twitter LinkedIn
GreenLight Biosciences raised an oversubscribed $102 million Series D funding round, enabling the Boston-based company to rapidly expand production of its RNA products for agricultural and life scie... |
| 16.06.2020 | Baird Capital Portfolio Company GreenLight Biosciences Raises $102M Series D Funding Round | Today, Baird Capital portfolio company GreenLight Biosciences (GreenLight) announced it raised an oversubscribed $102 million, Series D round of funding from new and existing investors. GreenLight aims to rapidly expand the production of it... |
| 12.05.2020 | GreenLight Biosciences Raises $17M Financing Round | GreenLight Biosciences today announced it has closed an oversubscribed $17M special purpose funding round from new and existing investors to build out its scalable mRNA production capability targeting the production of billions of doses of ... |
| 12.05.2020 | GreenLight Biosciences raises $17M to ramp mRNA production for COVID-19 vaccine candidate trials | One of the approaches therapeutics companies are taking to developing vaccines for COVID-19 relies on what’s called an mRNA (messenger RNA, which essentially provides cells with protein production instructions) vaccine, a relatively novel m... |
| 12.05.2020 | GreenLight Biosciences raises $17M to scale coronavirus vaccine development | GreenLight Biosciences is making a big pivot.
The Medford-based startup's flagship product is a pesticide alternative: an RNA-based product that targets harmful pests by modifying their gene expressions and weakening them through a natural ... |
| 12.05.2020 | Baird Capital invests in $17M round for GreenLight Biosciences | GreenLight Biosciences is making a big pivot.
The Massachusetts-based startup’s flagship product is a pesticide alternative: an RNA-based product that targets harmful pests by modifying their gene expressions and weakening them through a na... |
| 12.05.2020 | GreenLight Biosciences Grabs $17M |
BOSTON, MA, GreenLight Biosciences has closed an oversubscribed $17 million special purpose funding round.
>> Click here for more funding data on GreenLight Biosciences
>> To export GreenLight Biosciences funding data to PDF... |
| 12.05.2020 | Baird Capital Portfolio Company GreenLight Biosciences Raises $17M for COVID-19 Vaccine Production | |
| 31.03.2020 | Chicago VC Firm Baird Capital Raises $215M for Its Latest Fund | The latest nine-figure VC fund just closed in Chicago, which should come as a welcome sign to the city's startup scene that's preparing for an uncertain business climate amid the coronavirus crisis.
Baird Capital, the Chicago-based investme... |
| 30.04.2019 | 7 Top Agtech Startups Defining the Future of Agriculture | AgriFood tech is a maturing market, as evidenced by the swell in investing activity last year. Startups in the space attracted nearly $17 billion in investment capital–a 43% increase from the previous year, according to data from AgFunder. ... |
| 21.04.2019 | How Chicago Fuels Food-Focused Innovation | Today, Chicago’s newest food business accelerator, The Hatchery, will celebrate its grand opening. A non-profit incubator supported by companies like Conagra and Kellogg’s, The Hatchery will support entrepreneurs in growing successful food-... |
| 22.03.2019 | 11 Under-The-Radar Chicago VCs You Should Know About | In my most-recent Forbes article, I shared about 12 Chicago-based VCs that are behind hot startups both within our region, like G2 Crowd, and beyond, like SpaceX. These firms tend to get a lot of buzz and make national headlines, but they a... |
| 24.01.2019 | TechAccel Launches RNAissance Ag; Invests in GreenLight Biosciences | TechAccel, a Kansas City-based technology and venture development company, has launched RNAissance Ag LLC, a new company that holds the exclusive license to RNA-interference technology in partnership with the Donald Danforth Plant Science C... |
| 24.01.2019 | TechAccel and Donald Danforth Center Launch RNAissance to Create Environmentally-Friendly Pesticides | TechAccel, the venture development organization, and Donald Danforth Center for Life Sciences, the leading plant science research institute, have created a new startup called RNAissance.
RNAissance plans to use RNAi technology to create pes... |
| 24.01.2019 | Top startup news for today, Thursday, January 24, 2019 | Good morning! Here are some of the top technology startup news stories for today, Thursday, January 24.
TechAccel launches RNAissance Ag; Invests in biotech startup GreenLight Biosciences. TechAccel, a Kansas City-based venture and technol... |
| 09.01.2019 | Term Sheet — Wednesday, January 9 | AN IPO FREEZE
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
We were supposed to kick off 2019 with a wave of IPOs, including some of the biggest tech offerings we’ve seen in years. W... |
| 09.01.2019 | Daily funding roundup - January 9th, 2019 | Totle raised $1M; Yallacompare raised $8M; GAN transforms $15M; GreenLight Biosciences raised $50M
Totle: By aggregating the liquidity of the top decentralized exchanges, Totle is providing a ERC-20 token trading platform. Totle has raised ... |
| 09.01.2019 | GreenLight Biosciences Grabs $50M |
MEDFORD, MA, GreenLight Biosciences announced today a $50 million first closing of its latest funding round.
>> Click here for more funding data on GreenLight Biosciences
>> To export GreenLight Biosciences funding data to P... |
| 08.01.2019 | GreenLight Biosciences Raises $50M in Funding | GreenLight Biosciences, Inc., a Medford, MA-based bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, raised $50m in the first closing of its latest funding round.
The round was led by S2G... |
| 08.01.2019 | GreenLight Biosciences Announces $50 Million Funding Round | GreenLight Biosciences, Inc., the bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, announced today a $50 Million first closing of its latest funding round. The round was led by S2G Vent... |
| 06.08.2018 | Startup Technologies Making GMO Less Controversial | In the last 10 years, the GMO (genetically modified organism) debate hasn’t changed much. Despite a robust chorus of mainstream publications breaking down GMO myths and at least one former anti-GMO activist making a very public reversal, no... |
| 05.12.2017 | Reflections of an Agtech VC: Gabriel Wilmoth Leaves Syngenta Ventures to Join Ag Startup | Gabriel Wilmoth has left Syngenta Ventures, where he was investment director, to join ag startup Growers, an on-farm service that helps farmers use technology to simplify their business, as the chief operating officer.
Wilmoth joined Syngen... |
| 14.09.2017 | GreenLight Biosciences Closes $18M Series D Financing | GreenLight Biosciences, Inc., a Medford, Mass.-based developer of a platform to develop a portfolio of RNA-based products for use in agriculture, completed a $18m Series D round of financing.
The round was led by Fall Line Capital, with par... |
| 13.09.2017 | Greenlight Biosciences Raises $18m Series D for RNAi Biopesticide | Biological pesticide firm Greenlight Biosciences has raised an $18 million Series D round led by farmland and agtech fund investor Fall Line Capital. AgriFood specialists S2G Ventures and Lewis and Clark Ventures also participated in the ro... |
| 13.09.2017 | Term Sheet — Wednesday, September 13 | CRYPTO DRAMA
JAMIE DIMON VS. THE INTERNET: J.P. Morgan CEO Jamie Dimon lit the Internet on fire yesterday after his remarks about how Bitcoin is “a fraud” and how he would fire any employee trading bitcoin for being “stupid.”
Paid Content W... |
| 13.09.2017 | GreenLight Biosciences Announces $18M Series D Financing | GreenLight Biosciences, Inc. announced today the completion of its $18 million Series D round of financing led by Fall Line Capital. S2G Ventures, Lewis and Clark Ventures, and Macro Capital Investments participated in the round, along with... |
| 06.08.2015 | Why MLS Capital Fund II Invested in Provivi & GreenLight Biosciences | MLS Capital Fund II, co-managed by Spruce Capital Partners and Xeraya Capital, announced the first two investments from the fund at the 12th Annual BIO World Congress on Industrial Biotechnology on July 21, 2015.
Provivi, a bio-based pest c... |
| 24.07.2015 | News in Brief: AgTech Sectors that Scored Funds this Week | Catch up on recent fundings in AgTech with the following list of News in Brief.
Biotech Companies Boost their Bucks
The MLS Capital Fund II has announced its first two investments — both in biotech. Co-managed by Spruce Capital Partners and... |
| 22.07.2015 | GreenLight Biosciences Raises Series C Funding | GreenLight Biosciences, a Medford, Mass.-based developer of a cell-free approach to microbial chemical production, raised a Series C round of funding.
The amount of the deal remained undisclosed.
The round was led by MLS Capital Fund II, co... |
| - | Manage your consent preferences
Baird Capital invests in $17M round for GreenLight Biosciences | - |
| - | Manage your consent preferences
GreenLight Biosciences raises $102M in Series D to bring RNA products to 'patients and farmers alike' | - |
| - | Manage your consent preferences
GreenLight Biosciences raises $17M to scale coronavirus vaccine development | - |
